US to no longer dis­trib­ute Eli Lil­ly’s bam­lanivimab alone due to coro­n­avirus vari­ants

4 weeks ago
Pharma
FDA+

Bris­tol My­ers Squibb out­races the pack to a late-stage tri­al win for its LAG-3/PD-1 an­ti­body com­bo in melanoma

4 weeks ago
R&D
Pharma

T cell ther­a­py play­er Lyell pre­pares to open $65M man­u­fac­tur­ing fa­cil­i­ty in the Seat­tle area

4 weeks ago
Manufacturing

UP­DAT­ED: Mon­cef Slaoui of­fers his 'deep re­gret' over sex­u­al ha­rass­ment charge — while get­ting the boot from biotech posts

4 weeks ago
People

UP­DAT­ED: Glax­o­SmithK­line fires Mon­cef Slaoui as Gal­vani chair af­ter on­go­ing probe sub­stan­ti­ates sex­u­al ha­rass­ment al­le­ga­tions

5 weeks ago
People

Covid-19 roundup: EU cracks down fur­ther on vac­cine ex­ports; Pfiz­er en­ters race for Covid-19 pill

5 weeks ago
Coronavirus

Tougher reg­u­la­to­ry en­vi­ron­ment for bio­phar­ma? De­bate en­sues

5 weeks ago
Pharma
FDA+

Ex­clu­sive: An in­dus­try con­sor­tium wants to stan­dard­ize cell track­ing for re­gen­er­a­tive meds. Could that avert a dis­as­ter?

5 weeks ago
Cell/Gene Tx
Manufacturing

NIH pan­el let­ter ac­cused As­traZeneca of em­bell­ish­ing the da­ta for its Covid-19 vac­cine — re­port

5 weeks ago
FDA+

No­var­tis’ $2B can­cer drug spurs ‘ground­break­ing’ PhI­II da­ta for prostate can­cer

5 weeks ago
R&D

No­vo Nordisk slammed with an RTF as the FDA rais­es CMC is­sues

5 weeks ago
FDA+

UP­DAT­ED: Mid­dle-of-the-night NIH state­ment rais­es con­cerns on As­traZeneca's US vac­cine tri­al read­out

5 weeks ago
Pharma
Coronavirus

Roche cuts bait on late-stage study of Hunt­ing­ton's med tomin­ersen, an Io­n­is im­port with pri­or safe­ty flags

5 weeks ago
R&D

Those NDA plans Odonate had for mid-'21? They're be­ing scrapped — along with the en­tire biotech — in a sud­den im­plo­sion

Last month
R&D

Xy­lo­Cor finds new back­ing to push re­gen­er­a­tive heart dis­ease gene ther­a­py deep­er in­to the clin­ic

Last month
Financing
Cell/Gene Tx

Roche claims key win in the $12B ear­ly-stage check­point race

Last month
R&D
Pharma

UP­DAT­ED: As­traZeneca read­ies April EUA fil­ing with 79% vac­cine ef­fi­ca­cy, first glimpse of el­der­ly da­ta and 100% pro­tec­tion against se­vere dis­ease in US tri­al

Last month
R&D
Coronavirus

Mer­ck­'s C-suite shake­up, Eli Lil­ly stirs fresh Alzheimer's con­tro­very, play by play of Am­gen's $2B buy­out, and more

Last month
Weekly

UK drug reg­u­la­tor to restart in­spec­tions at the end of March with a fo­cus on so­cial dis­tanc­ing

Last month
FDA+
Coronavirus

Mer­ck breathes a sigh of re­lief as Keytru­da-Lenvi­ma com­bo aces con­fir­ma­to­ry study in en­dome­tri­al can­cer

Last month
R&D
Pharma

Out­bid­ding 14 oth­ers and then them­selves: How Am­gen spent $2 bil­lion on a biotech that had been on the brink

Last month
Deals

Idera squelch­es any lin­ger­ing en­thu­si­asm as its lead TLR9 drug flunks PhI­II — bad­ly

Last month
R&D

UP­DAT­ED: In­side No­var­tis' months-long ef­forts to scale their ri­val­s' Covid-19 vac­cines

Last month
Coronavirus
Manufacturing

Catal­ent amps up plans to man­u­fac­ture J&J's Covid-19 vac­cine, adding vial fill­ing line in Italy

Last month
Manufacturing
First page Previous page 1234567 Next page Last page